States are pulling back coverage largely due to cost: monthly Medicaid spending on Wegovy alone exceeded $192 million in late 2024, and total GLP-1 spending across the program exceeded $3.5 billion in a single year
"I've never had stitches, so to have this C-section scar, I was in a really dark place and I wanted to be in a great place for my son." Afterwards, she used the motivation of becoming a new mother to push herself to lose the weight gradually
Biomed Rep 1(1):7176 Wang Q, Ou Y, Hu G, Wen C, Yue S, Chen C, Xu L, Xie J, Dai H, Xiao H, Zhang Y (2020) Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3/NF-B pathway in mice
So some people experience gastroparesis and constipation at the same time